Last reviewed · How we verify
NCT04335474
Surgical Versus Percutaneous Drainage in the Management of High Grade Pancreatic Trauma
trial testing Surgical drainage strategy in Trauma in 80 participants. Status unknown.
31 December 2022
Quick facts
| Lead sponsor | Nanjing PLA General Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 1 January 2020 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 March 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Surgical drainage strategy
- Percutaneous drainage strategy
Conditions studied
- Trauma — all drugs for Trauma →
- Pancreatic Trauma — all drugs for Pancreatic Trauma →
Sponsor
Nanjing PLA General Hospital
Who can join
Adults 18 to 75, any sex, with Trauma or Pancreatic Trauma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
High-grade pancreatic injury is rare, and the reported complication and mortality are high. The optimal management strategy according to high-grade injuries remains controversial. The present study compares surgical drainage with percutaneous drainage in the management of High-grade pancreatic trauma.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04335474
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Trauma
Currently open trials in the same condition.
- NCT07290634 — Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion · recruiting
- NCT07485231 — Nitric Oxide (NO) and Endothelial Dysfunction in Women With PTSD · NA · recruiting
- NCT07473336 — The Effectiveness of RAPID-Based Psychological First Aid Training · NA · active not recruiting
- NCT07278505 — Study of Cannabidiol and Neuroimaging on Stress · Phase 1, PHASE2 · recruiting
- NCT02880163 — REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam · NA · recruiting
Other Nanjing PLA General Hospital trials
Trials by the same sponsor.
- NCT04037267 — Endoscopic Intraventricular Hematoma Evacuation Surgery Versus EVD for IVH · NA · unknown
- NCT03117023 — The Addition of Dexmedetomidine on Postoperative Sleep for Middle-aged and Elderly Patients With Gastric Cancer · Phase 3 · unknown
- NCT03612206 — Effect of Early Enteral Nutrition on Serum Acetylcholine Level and Inflammation in Critically Ill Patients · completed
- NCT03589248 — Predictive Value of Transabdominal Intestine Sonography in Critically Ill Patients · completed
- NCT03466684 — BIA Guided-fluid Management in Postinjury Open Abdomen · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04335474 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nanjing PLA General Hospital
- Last refreshed: 6 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04335474.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing